CD4 and glioma: Overall, we envisage that the lower expression of C5AR1 in NL gliomas, by impacting negatively on MSR1-expressing M2 phenotype macrophages and positively on NK and CD4+/CD8+ T cells, favors anti-inflammatory and anti-tumoral cell signaling cascades.